Steven Seedhouse
Stock Analyst at Cantor Fitzgerald
(4.46)
# 1,120
Out of 4,574 analysts
311
Total ratings
44.1%
Success rate
10.2%
Average return
Main Sectors:
Stocks Rated by Steven Seedhouse
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABCL AbCellera Biologics | Maintained: Buy | $7 → $11 | $5.31 | +107.16% | 2 | Jul 16, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $15 | $3.08 | +387.01% | 3 | Jul 9, 2026 | |
| VKTX Viking Therapeutics | Maintained: Buy | $100 | $34.79 | +187.44% | 33 | Jul 1, 2026 | |
| BCRX BioCryst Pharmaceuticals | Maintained: Buy | $26 → $29 | $9.34 | +210.49% | 4 | Jun 30, 2026 | |
| HROW Harrow | Maintained: Buy | $88 | $38.45 | +128.87% | 7 | Jun 29, 2026 | |
| PHVS Pharvaris | Maintained: Buy | $46 | $34.17 | +34.62% | 6 | Jun 29, 2026 | |
| STO: VICO Vicore Pharma Holding AB (publ) | Initiated Coverage: Buy | kr 33.00 | kr 11.22 | +194.12% | 1 | Jun 8, 2026 | |
| ALGS Aligos Therapeutics | Maintained: Buy | $20 | $4.08 | +390.20% | 2 | May 28, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $266 | $153.36 | +73.45% | 3 | May 20, 2026 | |
| WVE Wave Life Sciences | Maintained: Buy | $34 → $13 | $5.81 | +123.75% | 9 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2 → $4 | $1.74 | +129.89% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $3.16 | +121.52% | 7 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.72 | +365.12% | 11 | Apr 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $21.44 | +49.25% | 5 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $2.49 | +301.61% | 1 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $2.51 | - | 4 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $19.73 | +102.74% | 2 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ¥1,130 | ¥239 | +372.80% | 1 | Mar 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $22 | $10.64 | +106.77% | 7 | Mar 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $43 | $19.44 | +121.19% | 3 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $49 | $29.64 | +65.32% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $250 | $271.77 | n/a | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 | $15.15 | n/a | 1 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 → $103 | $129.31 | n/a | 35 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.60 | n/a | 10 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $17 | $5.23 | n/a | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $51 | $103.87 | n/a | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $27 → $56 | $24.44 | n/a | 5 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $77 | $113.03 | n/a | 27 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $25 → $17 | $0.6215 | n/a | 4 | Jun 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $3.19 | n/a | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $94 → $78 | $10.73 | n/a | 15 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $38 | $110.57 | n/a | 1 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $544.51 | n/a | 6 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $5 | $0.136 | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $38 | $54.15 | n/a | 1 | Nov 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $5.53 | n/a | 11 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.5129 | n/a | 10 | May 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 | $5.94 | n/a | 4 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $202.19 | n/a | 16 | Jul 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $46.54 | n/a | 12 | Jun 13, 2021 |
AbCellera Biologics
Jul 16, 2026
Maintained: Buy
Price Target: $7 → $11
Current: $5.31
Upside: +107.16%
Opus Genetics
Jul 9, 2026
Maintained: Buy
Price Target: $15
Current: $3.08
Upside: +387.01%
Viking Therapeutics
Jul 1, 2026
Maintained: Buy
Price Target: $100
Current: $34.79
Upside: +187.44%
BioCryst Pharmaceuticals
Jun 30, 2026
Maintained: Buy
Price Target: $26 → $29
Current: $9.34
Upside: +210.49%
Harrow
Jun 29, 2026
Maintained: Buy
Price Target: $88
Current: $38.45
Upside: +128.87%
Pharvaris
Jun 29, 2026
Maintained: Buy
Price Target: $46
Current: $34.17
Upside: +34.62%
Vicore Pharma Holding AB (publ)
Jun 8, 2026
Initiated Coverage: Buy
Price Target: kr 33.00
Current: kr 11.22
Upside: +194.12%
Aligos Therapeutics
May 28, 2026
Maintained: Buy
Price Target: $20
Current: $4.08
Upside: +390.20%
Belite Bio
May 20, 2026
Maintained: Buy
Price Target: $266
Current: $153.36
Upside: +73.45%
Wave Life Sciences
May 18, 2026
Maintained: Buy
Price Target: $34 → $13
Current: $5.81
Upside: +123.75%
May 8, 2026
Maintained: Buy
Price Target: $2 → $4
Current: $1.74
Upside: +129.89%
May 8, 2026
Maintained: Buy
Price Target: $7
Current: $3.16
Upside: +121.52%
Apr 14, 2026
Maintained: Buy
Price Target: $8
Current: $1.72
Upside: +365.12%
Apr 7, 2026
Maintained: Buy
Price Target: $32
Current: $21.44
Upside: +49.25%
Apr 7, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $2.49
Upside: +301.61%
Apr 1, 2026
Maintained: Hold
Price Target: n/a
Current: $2.51
Upside: -
Mar 23, 2026
Maintained: Buy
Price Target: $40
Current: $19.73
Upside: +102.74%
Mar 17, 2026
Initiated Coverage: Buy
Price Target: ¥1,130
Current: ¥239
Upside: +372.80%
Mar 12, 2026
Rated: Buy
Price Target: $21 → $22
Current: $10.64
Upside: +106.77%
Feb 25, 2026
Reiterated: Buy
Price Target: $42 → $43
Current: $19.44
Upside: +121.19%
Feb 19, 2026
Reiterated: Buy
Price Target: $42 → $49
Current: $29.64
Upside: +65.32%
Apr 28, 2025
Initiated Coverage: Hold
Price Target: $250
Current: $271.77
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $22
Current: $15.15
Upside: n/a
Nov 8, 2024
Maintained: Buy
Price Target: $93 → $103
Current: $129.31
Upside: n/a
Nov 4, 2024
Downgraded: Hold
Price Target: n/a
Current: $2.60
Upside: n/a
May 10, 2024
Maintained: Buy
Price Target: $22 → $17
Current: $5.23
Upside: n/a
Apr 18, 2024
Maintained: Buy
Price Target: $24 → $51
Current: $103.87
Upside: n/a
Jan 3, 2024
Maintained: Buy
Price Target: $27 → $56
Current: $24.44
Upside: n/a
Oct 18, 2023
Maintained: Buy
Price Target: $84 → $77
Current: $113.03
Upside: n/a
Jun 23, 2023
Maintained: Buy
Price Target: $25 → $17
Current: $0.6215
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $33 → $35
Current: $3.19
Upside: n/a
May 5, 2023
Maintained: Buy
Price Target: $94 → $78
Current: $10.73
Upside: n/a
May 4, 2023
Upgraded: Buy
Price Target: $38
Current: $110.57
Upside: n/a
Dec 19, 2022
Upgraded: Hold
Price Target: n/a
Current: $544.51
Upside: n/a
Dec 7, 2022
Maintained: Buy
Price Target: $15 → $5
Current: $0.136
Upside: n/a
Nov 9, 2022
Maintained: Buy
Price Target: $38
Current: $54.15
Upside: n/a
Aug 10, 2022
Downgraded: Sell
Price Target: n/a
Current: $5.53
Upside: n/a
May 18, 2022
Downgraded: Hold
Price Target: n/a
Current: $0.5129
Upside: n/a
Aug 6, 2021
Maintained: Buy
Price Target: $18
Current: $5.94
Upside: n/a
Jul 22, 2021
Maintained: Hold
Price Target: n/a
Current: $202.19
Upside: n/a
Jun 13, 2021
Maintained: Sell
Price Target: n/a
Current: $46.54
Upside: n/a